array(3) { ["company_details"]=> array(13) { ["name"]=> string(29) "Regeneron Pharmaceuticals Inc" ["slug"]=> string(38) "c469a-us-regeneron-pharmaceuticals-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/b5187988-884a-43b7-980d-e1555548ab77" ["description"]=> string(868) "At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. " ["address_street"]=> string(25) "777 Old Saw Mill River Rd" ["address_place"]=> string(9) "Tarrytown" ["address_region"]=> string(8) "New York" ["founding_date"]=> string(10) "1988-02-08" ["website_domain"]=> string(13) "regeneron.com" ["website_url"]=> string(25) "https://www.regeneron.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(10368) ["article_count"]=> int(2748) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(62) "Regeneron denied safe harbour defence in COVID-19 drug dispute" ["snippet_en"]=> string(62) "Regeneron denied safe harbour defence in COVID-19 drug dispute" ["url"]=> string(108) "https://www.lifesciencesipreview.com/americas/regeneron-denied-safe-harbour-defence-in-covid-19-drug-dispute" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a12974d7-7a49-43b1-9664-9280d7f77f17" ["source"]=> string(24) "lifesciencesipreview.com" ["publication_date"]=> string(10) "2024-10-09" ["categories"]=> array(1) { [0]=> string(8) "Epidemic" } } [1]=> array(7) { ["title_en"]=> string(94) "WHO delivers drugs for the treatment of Ebola to the N’Zérékoré epidemic treatment center" ["snippet_en"]=> string(279) "As part of the response against Ebola virus disease, Dr Mamadou Oury Baldé, Emergency Manager at WHO, on behalf of the WHO Representative, proceeded, this Monday, February 22, 2021, to the delivery of a batch of drugs for the treatment of Ebola patients at the Ebola care center" ["url"]=> string(126) "https://www.afro.who.int/fr/news/loms-livre-des-medicaments-pour-le-traitement-debola-au-centre-de-traitement-des-epidemies-de" ["image_url"]=> string(78) "https://images.businessradar.com/articles/979c44c7-a71b-47a9-88a3-4289519bd2f2" ["source"]=> string(7) "who.int" ["publication_date"]=> string(10) "2024-10-05" ["categories"]=> array(1) { [0]=> string(8) "Epidemic" } } [2]=> array(7) { ["title_en"]=> string(64) "Regeneron 'Safe Harbor' Argument Rejected in Covid Cocktail Suit" ["snippet_en"]=> string(253) "Regeneron Pharmaceuticals Inc.’s infringement of a California biotechnology company’s patent for technology used to develop its Covid-19 “antibody cocktail” isn’t immunized by the US Patent Act’s safe harbor provision, a federal judge ruled." ["url"]=> string(99) "https://news.bloomberglaw.com/ip-law/regeneron-safe-harbor-argument-rejected-in-covid-cocktail-suit" ["image_url"]=> NULL ["source"]=> string(16) "bloomberglaw.com" ["publication_date"]=> string(10) "2024-10-05" ["categories"]=> array(4) { [0]=> string(10) "Litigation" [1]=> string(5) "Legal" [2]=> string(8) "Epidemic" [3]=> string(21) "Intellectual Property" } } [3]=> array(7) { ["title_en"]=> string(65) "400 hours’ diving as bio-student stands up for tumorous turtles" ["snippet_en"]=> string(158) "Hawaiian high-school student Maddux Springer was diving in Kaneohe Bay, Oahu during the Covid-19 pandemic when he started noticing the number of green turtles" ["url"]=> string(118) "https://divernet.com/world-dives/north-central-america/400-hours-diving-as-bio-student-stands-up-for-tumorous-turtles/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a165f5c9-a3c5-485d-aab6-d7c1b39efff3" ["source"]=> string(12) "divernet.com" ["publication_date"]=> string(10) "2024-06-23" ["categories"]=> array(4) { [0]=> string(17) "Academic Research" [1]=> string(5) "Award" [2]=> string(5) "Event" [3]=> string(8) "Epidemic" } } [4]=> array(7) { ["title_en"]=> string(70) "The Greek head of the research on the corona virus vaccine in New York" ["snippet_en"]=> string(205) "Dr. Christos Kyratsous, vice president and head of infectious disease and vector technologies research at Regeneron is leading the coronavirus vaccine research in New York. The 39-year-old scientist, the.." ["url"]=> string(119) "https://www.ellines.com/erga-ellinon/48118-o-ellinas-epikefalis-tis-ereunas-gia-to-embolio-tou-koronoiou-sti-nea-yorki/" ["image_url"]=> NULL ["source"]=> string(11) "ellines.com" ["publication_date"]=> string(10) "2024-05-21" ["categories"]=> array(3) { [0]=> string(17) "Academic Research" [1]=> string(8) "Epidemic" [2]=> string(5) "R & D" } } [5]=> array(7) { ["title_en"]=> string(59) "Monoclonal antibodies: how much they cost and how they work" ["snippet_en"]=> string(181) "The Minister of Health has issued an ordinance authorizing the extraordinary use of monoclonal antibodies for the treatment of Covid-19. Here's how they work and how much they cost." ["url"]=> string(73) "https://www.money.it/Anticorpi-monoclonali-quanto-costano-come-funzionano" ["image_url"]=> NULL ["source"]=> string(8) "money.it" ["publication_date"]=> string(10) "2024-05-20" ["categories"]=> array(1) { [0]=> string(8) "Epidemic" } } [6]=> array(7) { ["title_en"]=> string(130) "Jacob Gross: Finalist in the Prestigious Regeneron Science Talent Search Competition for COVID-19 Antibody Research - News Purpose" ["snippet_en"]=> string(155) "Allyson Weseley, a science teacher at Roslyn High School, has nurtured the talents of Jacob Gross, a senior student who has been selected as a finalist for" ["url"]=> string(139) "https://newspurpose.com/jacob-gross-finalist-in-the-prestigious-regeneron-science-talent-search-competition-for-covid-19-antibody-research/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/6f97189a-ec03-472b-9156-8d05ffc1491d" ["source"]=> string(15) "newspurpose.com" ["publication_date"]=> string(10) "2024-03-07" ["categories"]=> array(3) { [0]=> string(17) "Academic Research" [1]=> string(5) "Award" [2]=> string(8) "Epidemic" } } [7]=> array(7) { ["title_en"]=> string(104) "Do intellectual property rights hinder or promote vaccine development? Doctors Without Borders tells you" ["snippet_en"]=> string(106) "Myth: Intellectual property rights enable breakthroughs in the development of COVID-19 drugs and vaccines." ["url"]=> string(38) "https://www.coolloud.org.tw/node/95865" ["image_url"]=> string(78) "https://images.businessradar.com/articles/6271f580-5986-4c05-a5b8-32b6ce02699c" ["source"]=> string(15) "coolloud.org.tw" ["publication_date"]=> string(10) "2024-03-04" ["categories"]=> array(6) { [0]=> string(8) "Epidemic" [1]=> string(21) "Competitive Behaviour" [2]=> string(24) "Access and affordability" [3]=> string(11) "Competition" [4]=> string(21) "Intellectual Property" [5]=> string(14) "Product Launch" } } [8]=> array(7) { ["title_en"]=> string(61) "Monoclonal antibodies: a new treatment to counter long COVID?" ["snippet_en"]=> string(130) "A new small study reveals that a treatment used to treat acute infection caused by Covid-19 was also effective against long Covid." ["url"]=> string(49) "https://francais.medscape.com/voirarticle/3610921" ["image_url"]=> string(78) "https://images.businessradar.com/articles/66dde446-8668-4abe-b158-b56fe6268b72" ["source"]=> string(12) "medscape.com" ["publication_date"]=> string(10) "2023-12-29" ["categories"]=> array(1) { [0]=> string(8) "Epidemic" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(263) } [1]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(201) } [2]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(196) } [3]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(129) } [4]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(116) } [5]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(116) } [6]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(93) } [7]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(79) } [8]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(67) } [9]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(66) } [10]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(61) } [11]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(59) } [12]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(57) } [13]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(56) } [14]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(53) } [15]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(43) } [16]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(40) } [17]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(38) } [18]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(37) } [19]=> array(2) { ["name"]=> string(8) "Verdicts" ["count"]=> int(37) } [20]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(37) } [21]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(35) } [22]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(33) } [23]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(32) } [24]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(31) } [25]=> array(2) { ["name"]=> string(27) "Business Model & Innovation" ["count"]=> int(28) } [26]=> array(2) { ["name"]=> string(14) "Product Review" ["count"]=> int(28) } [27]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(25) } [28]=> array(2) { ["name"]=> string(11) "Sponsorship" ["count"]=> int(21) } [29]=> array(2) { ["name"]=> string(21) "Intellectual Property" ["count"]=> int(20) } } } c469a-us-regeneron-pharmaceuticals-inc